Ludwig J, Scally SW, Costa G, et al. npj Vaccines. 2023;8(1):52. doi:10.1038/s41541-023-00653-7
- April 24, 2023
Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model.
Share on linkedin
Share on reddit
Share on facebook
Share on twitter
Share on email